Medicare Enrolled
Dr. Warren Oberle, MD
Urology Physician · Austell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Oberle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oberle?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oberle
Dr. Warren Oberle is an urology physician in Austell, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Oberle performed 777 Medicare services across 568 unique beneficiaries.
Between the years covered by Open Payments, Dr. Oberle received a total of $14,498 from 50 pharmaceutical and/or device companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oberle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 777 Medicare services
$14,498 industry payments
Medicare Practice Summary
Medicare Utilization ↗777
Medicare services
Bottom 27% in GA for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
568
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~41 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
227 | $94 | $233 |
| PSA test (prostate cancer screening) | 127 | $18 | $109 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
103 | $2 | $21 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 60 | $133 | $964 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
37 | $56 | $696 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $121 | $350 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $60 | $136 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $140 | $246 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
29 | $25 | $111 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
20 | $27 | $58 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
19 | $935 | $8,320 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $60 | $165 |
| Partial kidney removal using endoscope Surgical removal of part of the kidney through a small incision using an endoscope. This minimally invasive technique allows for targeted tissue removal without large open incisions. |
12 | $1,164 | $4,597 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
11 | $260 | $3,516 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
11 | $8 | $78 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,498
Total received (2018-2024)
Avg $2,071/year across 7 years
Top 15% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
262
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,430 (58.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,068 (41.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,222
2023
$5,633
2022
$1,594
2021
$648
2020
$440
2019
$2,043
2018
$919
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$2,444
Bayer Healthcare Pharmaceuticals Inc.
$146
Janssen Biotech, Inc.
$116
ABBVIE INC.
$90
Merck Sharp & Dohme LLC
$86
PFIZER INC.
$56
Sumitomo Pharma America, Inc.
$55
Dendreon Pharmaceuticals LLC
$46
UROGEN PHARMA, INC.
$29
Boston Scientific Corporation
$27
AstraZeneca Pharmaceuticals LP
$24
Pacira Pharmaceuticals Incorporated
$23
Endo USA, Inc.
$23
Ferring Pharmaceuticals Inc.
$21
Myriad Genetic Laboratories, Inc.
$18
Innovation Technologies Inc
$15
Top 3 companies account for 84.0% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$7,094
INTUITIVE SURGICAL, INC.
$2,444
Janssen Biotech, Inc.
$615
Astellas Pharma US Inc
$462
Boston Scientific Corporation
$438
Blue Earth Diagnostics Limited
$271
Dendreon Pharmaceuticals LLC
$236
Bayer Healthcare Pharmaceuticals Inc.
$217
Bayer HealthCare Pharmaceuticals Inc.
$210
Axonics, Inc.
$193
Myovant Sciences Inc.
$181
PFIZER INC.
$174
AstraZeneca Pharmaceuticals LP
$170
NeoTract Inc.
$167
Merck Sharp & Dohme LLC
$163
EDAP TECHNOMED INC
$159
Antares Pharma, Inc.
$128
ABBVIE INC.
$90
C. R. Bard, Inc. & Subsidiaries
$86
Sumitomo Pharma America, Inc.
$83
Ferring Pharmaceuticals Inc.
$71
Endo Pharmaceuticals Inc.
$70
AngioDynamics, Inc.
$60
UroGen Pharma, Inc.
$53
Myriad Genetic Laboratories, Inc.
$52
Tolmar, Inc.
$47
UROGEN PHARMA, INC.
$45
Avadel Specialty Pharmaceuticals, LLC
$42
Amgen Inc.
$40
PROCEPT BioRobotics Corporation
$35
Merck Sharp & Dohme Corporation
$34
Ambu Inc.
$28
Baxter Healthcare
$27
AbbVie, Inc.
$26
E.R. Squibb & Sons, L.L.C.
$26
Alnylam Pharmaceuticals Inc.
$25
Novartis Pharmaceuticals Corporation
$24
Pacira Pharmaceuticals Incorporated
$23
Endo USA, Inc.
$23
Agiliti Surgical, Inc.
$20
Kowa Pharmaceuticals America, Inc.
$18
BOSTON SCIENTIFIC CORPORATION
$18
Hollister Incorporated
$18
Richard Wolf Medical Instruments Corp.
$16
BAXTER HEALTHCARE
$16
Innovation Technologies Inc
$15
UROVANT SCIENCES INC
$14
Travere Therapeutics, Inc.
$14
Janssen Pharmaceuticals, Inc
$12
Retrophin, Inc.
$5
Top 3 companies account for 70.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · AQUABEAM ROBOTIC SYSTEM · AVEED · AXXCESS · Androgel · Axonics · Axumin · BOTOX · DA VINCI SP · Da Vinci Surgical System · ERLEADA · Erleada · Exparel · FIRMAGON · FLOSEAL · GEMTESA · GENERAL THERAPIES · GENERAL BPH · GREENLIGHT · IMFINZI · INLAY OPTIMA · IRRISEPT · JATENZO · JELMYTO · KEYTRUDA · Koelis TRINITY Fusion Biopsy System · LYNPARZA · LithoVue · Lupron · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Noctiva · Nubeqa · OPDIVO · ORGOVYX · OTREXUP · OXLUMO · Onli · Otrexup · PLUVICTO · PROLARIS · PROVENGE · Prolaris · Prolia · REZUM · SPACEOAR · SUTENT · Seglentis · TRIA · Thiola · UroLift · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xofigo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
132
Per 100K population
17.2
County median income
$98,712
Nearest hospital
WELLSTAR COBB MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Oberle is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 15% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Oberle experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Oberle performed 227 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oberle receive payments from pharmaceutical companies?
Yes. Dr. Oberle received a total of $14,498 from 50 companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oberle's costs compare to other urology physicians in Austell?
Dr. Oberle's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oberle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Austell
Browse urology physicians in Austell ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology